Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAptitude Regulatory News (APTD)

Share Price Information for Aptitude (APTD)

Share Price is delayed by 15 minutes
Get Live Data
221.00    -1.00 (-0.45%)
Bid:
221.00
Ask:
232.00
Spread: 11.00 (4.977%)
Market Cap: £116.68m
APTD Live PriceLast checked at - London Stock Exchange

Intraday Aptitude Share Chart

Interim Management Statement

30 Oct 2014 07:00

RNS Number : 6537V
Microgen PLC
30 October 2014
 



microgen

www.microgen.com 30 October 2014

 

INTERIM MANAGEMENT STATEMENT

 

Microgen plc ('Microgen' or 'the Group') provides its Interim Management Statement covering the period from 1 July 2014 to the date of this announcement. Microgen released its interim results for the six months ended 30 June 2014 on 21 July 2014.

 

There have been no significant changes since 1 July 2014 in the trading or financial position of Microgen and its balance sheet remains strong. Both of the Group's businesses, Aptitude Software and Financial Systems, continue to perform satisfactorily in line with the Board's current expectations. In line with the Group's seasonal cash flow cycle and the normal variation in timing of customer receipts the Group had cash at 30 September 2014 of £34.7 million (30 June 2014: £37.9 million) and net funds of £17.7 million (30 June 2014: £20.2 million).

 

Investment has continued in the Aptitude Software business with the release of the latest version of the Aptitude technology platform in October. This software version further extends the Aptitude Big Data processing capabilities enabling users to build data-driven applications deploying Aptitude's in-memory, in-database and in-Hadoop processing. In conjunction with this release, the Aptitude Software business has entered into a partnership with Cloudera, the leading distributor of Apache Hadoop. In October, the Aptitude Software business also released the Compact Edition of the Aptitude Accounting Hub, a pre-configured Aptitude-based divisional accounting hub and sub-ledger which complements the Aptitude Revenue Recognition Engine and the Aptitude Allocation Engine released earlier in the year.

 

In August, Aptitude Software signed a contract with a large North American telecommunications company, which is anticipated to generate revenues in excess of $5 million over its expected term. Discussions are also underway with a number of other telecommunications companies related to the potentially very high volume data processing demands associated with the new IFRS 15 (customer contract revenue recognition) accounting requirements.

 

Financial Systems' wealth management product for trust and fund administration, 5Series, continues to be well received in the market with three new contracts entered into since 1 July 2014. In line with the Board's strategy, the Financial Systems' Application Management business continues to decline slowly as some legacy products/solutions approach end of life. A number of add-on acquisitions in the wealth management sector continue to be progressed, although the Board remains prudent and, as always, there can be no certainty that any acquisitions will be completed.

 

Microgen is continuously identifying and evaluating businesses and strategic investments which the Board believes may benefit from being operated as a business unit under Microgen's stewardship. The Board will maintain its prudent approach and there can be no certainty that any material acquisition will be completed.

 

Contacts

Martyn Ratcliffe, Chairman 020-7496-8100

Philip Wood, Group Finance Director

 

Lucy Delaney, FTI Consulting 020-3727-1131

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSMLBPTMBTTBFI
Date   Source Headline
24th Apr 20123:51 pmRNSDirectorate Change
24th Apr 201211:14 amRNSResult of AGM
24th Apr 20127:00 amRNSInterim Management Statement
2nd Apr 201212:03 pmRNSBlocklisting Interim Review
30th Mar 20121:23 pmRNSTotal Voting Rights
26th Mar 20123:14 pmRNSDirector/PDMR Shareholding
20th Mar 20121:11 pmRNSAnnual Information Update
12th Mar 20126:21 pmRNSHolding(s) in Company
12th Mar 201212:03 pmRNSPDMR Announcement
6th Mar 20124:37 pmRNSPosting of Annual Report and Notice of AGM
27th Feb 20127:00 amRNSPreliminary Results
14th Feb 201211:16 amRNSNotice of Results
2nd Feb 201210:18 amRNSAppointment of Non-Executive Director
26th Jan 20122:23 pmRNSHolding(s) in Company
16th Jan 20121:11 pmRNSBlocklisting Interim Review
8th Dec 201112:29 pmRNSDirector Declaration
30th Nov 20111:48 pmRNSTotal Voting Rights
9th Nov 20113:33 pmRNSDirector/PDMR Shareholding
1st Nov 20117:00 amRNSInterim Management Statement and Special Dividend
31st Oct 20111:39 pmRNSHolding(s) in Company
31st Oct 20111:34 pmRNSTotal Voting Rights
12th Oct 20113:35 pmRNSApplication for Block Listing
12th Oct 20111:12 pmRNSDirector Declaration
7th Oct 20112:10 pmRNSDirector Declaration
5th Oct 201111:39 amRNSApplication for Block Listing
30th Sep 20114:13 pmRNSTotal Voting Rights
27th Sep 20115:27 pmRNSBlock Listing Return
8th Sep 20114:24 pmRNSHolding(s) in Company
7th Sep 20113:15 pmRNSDirector/PDMR Shareholding
5th Sep 20113:29 pmRNSHolding(s) in Company
5th Sep 20111:50 pmRNSHolding(s) in Company
31st Aug 20114:53 pmRNSTotal Voting Rights
31st Aug 20119:25 amRNSHolding(s) in Company
31st Aug 20118:33 amRNSDirectorship in Another PLC
31st Aug 20117:00 amRNSDirectorate Change
15th Aug 20111:21 pmRNSDirector/PDMR Shareholding
21st Jul 20117:00 amRNSInterim Results
7th Jul 20117:00 amRNSTrading Update
1st Jul 20119:00 amRNSBlocklisting Interim Review
30th Jun 20113:07 pmRNSTotal Voting Rights
24th Jun 20112:17 pmRNSHolding(s) in Company
23rd Jun 201111:45 amRNSHolding(s) in Company
21st Jun 20114:44 pmRNSHolding(s) in Company
24th May 201110:00 amRNSDirector Declaration
4th May 20119:43 amRNSHolding(s) in Company
19th Apr 20119:34 amRNSAGM Statement
19th Apr 20117:00 amRNSInterim Management Statement
31st Mar 20119:08 amRNSTotal Voting Rights
30th Mar 201112:25 pmRNSDirector/PDMR Shareholding
25th Mar 201110:10 amRNSBlock Listing Return

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.